DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity

References

1. Arts E. J., Wainberg M. A. 1994; Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription. Antimicrobial Agents and Chemotherapy in press
   [Google Scholar]
2. Barat C., Legrice S. F. J., Darlix J. L. 1991; Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA^lys3. Nucleic Acids Research 19:751–756
   [Google Scholar]
3. Barat C., Lullen V., Schatz O., Keith G., Nugeyre M. T., Gruninger-Leitch F., Barré-Sinoussi F., Legrice S. F. J., Darlix J. L. 1989; HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO Journal 8:3279–3286
   [Google Scholar]
4. Biswal N., Mccain B., Benyesh-Melnick M. 1971; The DNA of murine sarcoma-leukemia virus. Virology 45:697–706
   [Google Scholar]
5. Chaconas G., Van de Sande J. H. 1980; 5′γ-³²P-labelling of RNA and DNA restriction fragments. Methods in Enzymology 65:75–88
   [Google Scholar]
6. Craven R. C., Bennet R. P., Wills J. W. 1991; Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly. Journal of Virology 65:6205–6217
   [Google Scholar]
7. Crawford S., Goff S. P. 1984; A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. Journal of Virology 53:899–907
   [Google Scholar]
8. Davis N. K., Rueckert R. R. 1972; Properties OF a ribonucleo-protein particle isolated from Nonidet P-40-treated Rous sarcoma virus. Journal of Virology 10:1010–1020
   [Google Scholar]
9. Ferris A. L., Hizi A., Showalter S. D., Pichuantes S., Babe L., Craik C. S., Hughes S. M. 1990; Immunologic and proteolyticanalysis of HIV-1 reverse transcriptase structure. Virology 175:456–464
   [Google Scholar]
10. Furman P. A., Fyfe J. A., St.Clair M. H., Weinhold K., Rideout J. L., Freeman G. A., Nusinoff-Lehrman S., Bolognesi D. P., Broder S., Mitsuya H., Barry D. W. 1986; Phosphorylation of 3′-azido-3′-deoxythymidine and selection interaction of the 5′-triphophate with human immunodeficiency virus reverse transcriptase. Proceedings of the National Academy of Sciences, U.S.A 83:8333–8337
    [Google Scholar]
11. Ganem D., Varmus H. E. 1987; The molecular biology of the hepatitis B viruses. Annual Review of Biochemistry 56:651–693
    [Google Scholar]
12. Gao W.-Y., Cara A., Gallo R. C., Lori F. 1993; Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type-1 replication. Proceedings of the National Academy of Sciences, U.S.A 90:8925–8929
    [Google Scholar]
13. Geleziunas R., Arts E. J., Boulerice F., Goldman H., Wainberg M. A. 1993; Effects of 3′-azido-3′-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Antimicrobial Agents and Chemotherapy 37:1305–1312
    [Google Scholar]
14. Gopalakrishnan V., Peliska J. A., Benkovic J. 1992; Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationships between the polymerase and RNase H activities. Proceedings of the National Academy of Sciences, U.S.A 89:10763–10767
    [Google Scholar]
15. Gottlinger M. G., Sodroski J. G., Haseltine W. A. 1989; Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A 86:5781–5785
    [Google Scholar]
16. Haseltine W. A., Kleid D. G., Panet A., Rothenberg E., Baltimore D. 1976; Ordered transcription of RNA tumour virus genomes. Journal of Molecular Biology 26:4298–4032
    [Google Scholar]
17. Huang P., Farquhar D., Plunkett W. 1990; Selective action of 3′-azido-3′-deoxythymidine 5′-triphosphate on viral reverse transcriptase and human DNA polymerase. Journal of Biological Chemistry 265:11914–11918
    [Google Scholar]
18. Jacobsen H., Ahlborn-Laake L., Gugel R., Mous J. 1992; Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease. Journal of Virology 66:5087–5091
    [Google Scholar]
19. Jiang M., Mak J., Wainberg M. A., Parniak M. A., Cohen E., Kleiman L. 1992; Variable tRNA content in HIV-1_IIIB. Biochemical and Biophysical Research Communications 185:1005–1015
    [Google Scholar]
20. Kleiman L., Caudry S., Boulerice F., Wainberg M. A., Parniak M. A. 1991; Incorporation of tRNA into normal and mutant HIV-1. Biochemical and Biophysical Research Communications 174:1272–1280
    [Google Scholar]
21. Larder B., Purifoy D., Powell K., Darby G. 1987; AIDS virus reverse transcriptase defined by high level expression in Escherichia coli. EMBO Journal 6:3133–3137
    [Google Scholar]
22. Levinson W., Bishop J. M., Quintrell N., Jackson J. 1970; Presence of DNA in Rous sarcoma virus. Nature; London: 2271023–1025
    [Google Scholar]
23. Lori F., Veronese F., de Vico A. L., Lusso P., Reitz M. S., Gallo R. C. 1992; Viral DNA carried by human immunodeficiency virus type 1 virions. Journal of Virology 66:5067–5074
    [Google Scholar]
24. Lowe D. M., Aitken A., Bradley C., Darby G. K., Larder B. A., Powell K. L., Purifoy D. J. M., Tisdale M., Stammers D. K. 1988; HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis. Biochemistry 27:8884–8889
    [Google Scholar]
25. Luo G., Taylor J. 1990; Template switching by reverse transcriptase during DNA synthesis. Journal of Virology 64:4321–4328
    [Google Scholar]
26. Mitsuya H., Weinhold K. J., Furman P. A., St. Clair M. H., Lehrman S. N., Gallo R. C., Bolognesi D., Barry D. W., Broder S. 1985; 3′-Azido-3′-deoxythymidine (BWA509U): an antiviral agent that inhibits the infectivity and cytopathic effects of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proceedings of the National Academy of Sciences, U.S.A 82:7096–7100
    [Google Scholar]
27. Omer C. A., Resnick R., Faras A. J. 1984; Evidence for involvement of an RNA primer in initiation of strong-stop plus DNA synthesis during reverse transcriptase in vitro. Journal of Virology 50:465–470
    [Google Scholar]
28. Panganiban A. T., Fiore D. 1988; Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 241:1064–1069
    [Google Scholar]
29. Park J., Morrow C. D. 1992; The nonmyristylated Pr160^gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55^gag and is incorporated into virus-like particles. Journal of Virology 66:6304–6313
    [Google Scholar]
30. Peliska J. A., Benkovic S. J. 1992; Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258:1112–1118
    [Google Scholar]
31. Peng C., Ho B. K., Change T. W., Chang N. T. 1989; Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. Journal of Virology 63:2550–2556
    [Google Scholar]
32. Peng C., Chang N. T., Chang T. W. 1991; Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells. Journal of Virology 65:2751–2756
    [Google Scholar]
33. Restle T., Muller B., Goody R. S. 1990; Dimerization of human immunodeficiency virus type 1 reverse transcriptase: a target for chemotherapeutic intervention. Journal of Biological Chemistry 265:8986–8988
    [Google Scholar]
34. Richter-Cook N. J., Howard K. J., Cirino N. M., Wohrl B. M., Legrice S. F. J. 1992; Interaction of tRNA^lys3 with multiple forms of human immunodeficiency virus reverse transcriptase. Journal of Biological Chemistry 267:15952–15957
    [Google Scholar]
35. Sarih-Cottin L., Brodier B., Musier-Forsyth K., Andreola M. L., Barr P. J., Litvak S. 1992; Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA^lys as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides. Journal of Molecular Biology 226:1–6
    [Google Scholar]
36. Trono D. 1992; Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. Journal of Virology 66:4893–4900
    [Google Scholar]
37. Weiss R., Teich N., Varmus H., Coffin J. 1985 RNA Tumor Viruses New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
38. Zack J. A., Annigo S. J., Witsman S. R., Go A. S., Haislip A., Chen I. S. Y. 1990; HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213–222
    [Google Scholar]
39. Zack J. A., Haislip A. M., Knogstad P., Chen I. S. Y. 1992; Incomplete reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function on intermediates in the retroviral life cycle. Journal of Virology 66:1717–1725
    [Google Scholar]